E11.349 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema

Name of the Condition

• Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema

Summary

Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema is a condition where chronic high blood sugar levels cause significant damage to the retinal blood vessels, leading to advanced retinal changes without new blood vessel growth (proliferation) and no fluid accumulation in the macula. This stage is characterized by widespread retinal ischemia, intraretinal microvascular abnormalities, and venous beading. While vision may not be severely impaired at this stage, the risk of progression to proliferative diabetic retinopathy or vision-threatening complications is high if not managed appropriately.

Causes

High blood sugar levels over time damage the small blood vessels in the retina, leading to severe nonproliferative diabetic retinopathy without macular edema. Prolonged hyperglycemia in type 2 diabetes triggers vascular changes, including capillary closure and retinal ischemia. Metabolic factors associated with diabetes, such as advanced glycation end products and oxidative stress, contribute to this ocular complication. Insulin resistance or insufficient insulin production in type 2 diabetes sustains hyperglycemia, accelerating retinal damage.

Risk Factors

• Poorly controlled blood glucose levels.
• Long duration of diabetes.
• Hypertension and dyslipidemia.
• Smoking.
• Obesity and sedentary lifestyle.

Symptoms

• Blurred vision.
• Floaters or spots in the visual field.
• Difficulty seeing at night.
• Reduced color perception.
• Asymptomatic in early stages.

Diagnosis

Diagnosis involves a comprehensive eye examination, including dilated retinal imaging (e.g., fundus photography or optical coherence tomography) to assess retinal blood vessels and rule out macular edema. Visual acuity testing and fluorescein angiography may be used to evaluate retinal ischemia and microvascular abnormalities. Blood glucose and HbA1c levels are typically reviewed to confirm underlying type 2 diabetes.

Treatment Options

Management focuses on controlling blood sugar, blood pressure, and lipid levels to slow retinal progression. Regular eye exams are essential for monitoring. Treatment may include laser photocoagulation to reduce ischemia or anti-VEGF therapy if macular edema develops. Lifestyle modifications, such as diet and exercise, support overall diabetes control.

Prognosis and Follow-Up

Prognosis depends on timely intervention and glycemic control. Without proper management, severe nonproliferative diabetic retinopathy may progress to proliferative diabetic retinopathy, increasing the risk of vision loss. Follow-up eye exams are recommended every 3–6 months to monitor for changes.

Complications

• Progression to proliferative diabetic retinopathy.
• Vision-threatening complications, such as retinal detachment or hemorrhage.
• Increased risk of other diabetic eye diseases.

Lifestyle & Prevention

• Maintain tight blood glucose control through medication and lifestyle changes.
• Manage blood pressure and cholesterol levels.
• Avoid smoking and limit alcohol intake.
• Engage in regular physical activity and a balanced diet.
• Schedule annual dilated eye exams.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden vision changes, increased floaters, or eye pain. Regular follow-up with an ophthalmologist is critical for early detection and management of retinal changes.

Tips for Medical Coders

Document the absence of macular edema clearly in clinical notes, as this distinguishes the code from similar diabetic retinopathy codes with macular involvement. Ensure documentation supports the severity of nonproliferative changes (e.g., widespread ischemia, venous beading) to justify the "severe" designation. Code E11.349 is specific to type 2 diabetes; confirm the underlying diagnosis before application.